NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/04/2024
Back to search
Official data from USPTO
NAVIGATE BIOPHARMA SERVICES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NAVIGATE BIOPHARMA SERVICES
ST13
US500000087230060Class
35, 42
Filing
87230060
Registration
5541708
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
09/04/2024
Trademark type
Word
Nice classes
35, 42
Filing date
11/08/2016
Registration date
08/14/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/04/2024
Last transaction
09/04/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2017-12-00
First use in commerce
2017-12-00
Drawing code
4
Owner type
03
Owner location
CARLSBAD, CA
Examiner
ESTELL, BRITTANY
Current location
FILE DESTROYED
Holders and representatives
Holders
NAVIGATE BIOPHARMA SERVICES, INC.
Genoptix, Inc.
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting and management in the field of clinical trialsproviding information management servicesclinical data management servicesregulatory submission management services on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; business management consultingstrategic planning and business advisory services provided to others in the fields of pharmaceuticalsbiopharmaceuticals and medical devices
Class 42
Biopharmaceutical research and drug development services; custom biomarker assay development and validation services; diagnostics development services; project managementdata managementlogistics management for the clinical trials of others; consulting services in the field of designingplanning and conducting clinical trials for others; clinical trial testing services to support the clinical trials of others; consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticsgenetic science; biotechnology research and development services
Publications
History of USPTO decisions and trademark events.
31 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/04/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/04/2024
E815
TEAS SECTION 8 & 15 RECEIVED
02/14/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/14/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/10/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/10/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/10/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/10/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/10/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
08/14/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/13/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/12/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/22/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/22/2018
IUAF
USE AMENDMENT FILED
06/04/2018
EISU
TEAS STATEMENT OF USE RECEIVED
06/04/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/14/2017
EX1G
SOU EXTENSION 1 GRANTED
12/12/2017
EXT1
SOU EXTENSION 1 FILED
12/12/2017
EEXT
SOU TEAS EXTENSION RECEIVED
12/12/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/13/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/18/2017
PUBO
PUBLISHED FOR OPPOSITION
04/18/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/29/2017
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/22/2017
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
03/14/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/21/2017
DOCK
ASSIGNED TO EXAMINER
02/14/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/14/2016
NWAP
NEW APPLICATION ENTERED
11/11/2016
Continuous trademark protection
Get notified about every new filing that threatens NAVIGATE BIOPHARMA SERVICES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.